• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

氟喹诺酮C-3羧基等排体的合成及抗肿瘤活性Ⅲ.均三唑噁二唑甲硫醚衍生物

许秋菊, 侯莉莉, 仵钊锋, 岳喜波, 胡国强, 黄文龙

许秋菊, 侯莉莉, 仵钊锋, 岳喜波, 胡国强, 黄文龙. 氟喹诺酮C-3羧基等排体的合成及抗肿瘤活性Ⅲ.均三唑噁二唑甲硫醚衍生物[J]. 中国药科大学学报, 2013, 44(6): 511-514. DOI: 10.11665/j.issn.1000-5048.20130604
引用本文: 许秋菊, 侯莉莉, 仵钊锋, 岳喜波, 胡国强, 黄文龙. 氟喹诺酮C-3羧基等排体的合成及抗肿瘤活性Ⅲ.均三唑噁二唑甲硫醚衍生物[J]. 中国药科大学学报, 2013, 44(6): 511-514. DOI: 10.11665/j.issn.1000-5048.20130604
XU Qiuju, HOU Lili, WU Zhaofeng, YUE Xibo, HU Guoqiang, HUANG Wenlong. Synthesis and antitumor activity of fluoroquinolone C-3 isostere Ⅲ:s-triazole oxadiazole methylsulfide derivatives from pefloxacin[J]. Journal of China Pharmaceutical University, 2013, 44(6): 511-514. DOI: 10.11665/j.issn.1000-5048.20130604
Citation: XU Qiuju, HOU Lili, WU Zhaofeng, YUE Xibo, HU Guoqiang, HUANG Wenlong. Synthesis and antitumor activity of fluoroquinolone C-3 isostere Ⅲ:s-triazole oxadiazole methylsulfide derivatives from pefloxacin[J]. Journal of China Pharmaceutical University, 2013, 44(6): 511-514. DOI: 10.11665/j.issn.1000-5048.20130604

氟喹诺酮C-3羧基等排体的合成及抗肿瘤活性Ⅲ.均三唑噁二唑甲硫醚衍生物

基金项目: 国家自然科学基金资助项目(No.20872028,No.21072045)

Synthesis and antitumor activity of fluoroquinolone C-3 isostere Ⅲ:s-triazole oxadiazole methylsulfide derivatives from pefloxacin

  • 摘要: 为寻找由氟喹诺酮抗菌活性到抗肿瘤活性转化的有效途径,用均三唑和噁二唑分别作为培氟沙星C-3羧基的等排体和修饰基,设计合成了10个未见文献报道的双杂环硫醚1-乙基-6-氟-7-(4-甲基哌嗪-1-基)-3-[5-(5-芳基-[1,3,4]噁二唑-2-甲硫基)-4H-[1,2,4]-三唑-3-基]-喹啉(1H)-4-酮新化合物( 7a ~ 7j )。结果显示:对L1210、HL60和CHO 3种肿瘤细胞的体外抑制活性显著高于母体培氟沙星,表明C-3羧基不是抗肿瘤活性所必需的药效团,可被杂环等排体替换,进一步扩展了结构修饰的途径。
    Abstract: To discover an efficient route for the conversion of antibacterial fluoroquinolone to antitumor activity, s-triazole ring as an isostere modified by an oxadiazole ring corresponding to the C-3 carboxylic acid group for pefloxacin resulted in ten new title compounds, 1-ethyl- 6-fluoro-(4-methylypiperazin-1-yl)-3-[5-(5-aryl-[1, 3, 4]oxadiazol-2-methylsulfanyl)-4H-[1, 2, 4]-triazol-3-yl]-quinolin(1H)-4-ones( 7a - 7j ). Their structures were characterized by corresponding spectral data. The in vitro antitumor activity of the title compounds against L1210, HL60 and CHO cell lines exhibited significantly higher potency than parent pefloxacin. Thus, it suggests that it is necessary to retain a heterocycle instead of a C-3 carboxyl for antitumor fluoroquinolone compounds.
  • [1] Trippier PC,Jansen Labby K,Hawker DD,et al.Target- and mechanism-based therapeutics for neurodegenerative diseases:strength in numbers[J].J Med Chem,2013,56(8):3 121-3 147.
    [2] Bax BD,Chan PF,Eggleston DS,et al.Type IIA topoisomerase inhibition by a new class of antibacterial agents[J].Nature,2010,466(7 309):935-940.
    [3] Xu QJ,Hou LL,Wu XK,et al.Synthesis and antitumor and antibacterial activity of ciprofloquinolone bis-(C/C7hydrazone)s[J].J China Pharm Univ(中国药科大学学报),2013,44(1):35-38.
    [4] Hu GQ,Hou LL,Wang GQ,et al.Design,synthesis and antitumor activity of fluoroquinolone C3 heterocycles:bis-oxadiazole methylsulfide derivatives derived from ciprofloxacin[J].Acta Pharm Sin(药学学报),2012,47(8):1 017-1 022.
    [5] Zhou CH,Wang Y.Recent researches in triazole compounds as medicinal drugs[J].Curr Med Chem,2012,19(2):239-280.
    [6] Du QR,Li DD,Pi YZ,et al.Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents[J].Bioorg Med Chem,2013,21(8):2 286-2 297.
    [7] Wang GQ,Duan NN,Cao TY,et al.Antitumor fluoroquinolone C-3-isostere derivatives(Ⅰ):synthesis and activity of bis-oxadiazole methyl-sulfide derivatives[J].Chin J Appl Chem(应用化学),2012,29(7):769-774.
计量
  • 文章访问数:  1245
  • HTML全文浏览量:  0
  • PDF下载量:  1878
  • 被引次数: 0
出版历程
  • 刊出日期:  2013-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭